| http://www.w3.org/ns/prov#value | - FDA is taking this action because people with certain medical conditions may be at risk for serious or life-threatening electrolyte imbalances when using such products.FDA calls the new labeling requirements necessary to alert people with renal failure, kidney stones, or other conditions, and to assist those who wish to monitor their intake of calcium, magnesium, and potassium.
|
